日韩成人三级片,人人操操人人人,黄色AV一区二区,亚洲专一区,亚洲精品视频免费区,www.狠品,不卡观看AV,午夜不卡1卡2卡3,亚洲精品国产成人探花

×

R&D Progress

Guided by the philosophy of "building a global brand through continuous innovation", we constantly optimize our product mix and enrich our research pipelines. We devote ourselves to the development of medicines for diabetes and other endocrine disorders diseases, in a bid to enhance our market competitiveness and lead the domestic industry.

Milestones

  • 1985

    Fresh Ginseng oral liquid

  • 1989

    Zhennaoning Capsules

  • 1993

    Dongbao Gantai

  • 1998

    Human Insulin Injection (Gansuli?R)

  • 1999

    Isophane Protamine Human Insulin Injection(Gansulin?N)

  • 2002

    Mixed Protamine Human Insulin Injection(30R)(Gansulin?30R)

  • 2008

    Mixed Protamine Human Insulin Injection(50R)(Gansulin 50R?)

  • 2014

    Mixed Protamine Human Insulin Injection(40R)

  • 2019

    Insulin Glargine Injection

  • 2021

    Sitagliptin Phosphate Tablets

  • 2021

    Sitagliptin Phosphate and Metformin Hydrochloride Tablets

  • 2021

    Insulin Aspart Injection

  • 2022

    Insulin Aspart 30 Injection

  • 2022

    Insulin Aspart 50 Injection

  • 2022

    Repaglinide Tablets

  • 2023

    Empagliflozin Tablets

  • 2023

    Liraglutide Injection

  • 2025

    Etoricoxib Tablets

  • 1985

  • 1989

  • 1993

  • 1998

  • 1999

  • 2002

  • 2008

  • 2014

  • 2019

  • 2021

  • 2021

  • 2021

  • 2022

  • 2022

  • 2022

  • 2023

  • 2023

  • 2025

Product Pipeline

Product Name Indications Preclinical IND Clinical NDA
Mixed protamine zinc recombinant human insulin lispro injection 25R Diabetes requiring insulin therapy
Insulin Degludec and Liraglutide Injection Type 2 diabetes in adults
Ultra-fast Insulin Lispro Injection(BC Lispro) Type 1 diabetes in adults
Semaglutide Injection Type 2 diabetes in adults
THDBH110/THDBH110 Capsules (Oral Small-Molecule GLP-1 Receptor Agonist) Type 2 diabetes in adults
THDBH120 Injection (Dual GLP-1/GIP Receptor Agonist) Type 2 diabetes in adults
THDBH120 Injection (Dual GLP-1/GIP Receptor Agonist) Obesity
THDBH150/THDBH151 Tablets (XO/URAT1 Dual Inhibitor) Gout/hyperuricemia
连南| 昌宁县| 济阳县| 高密市| 综艺| 平阳县| 莲花县| 淳安县| 庐江县| 仪征市| 固安县| 佛山市| 竹山县| 西盟| 平罗县| 恩平市| 武鸣县| 鄯善县| 沾化县| 忻城县| 富民县| 瑞丽市| 博湖县| 桃源县| 庆云县| 黔东| 岗巴县| 横峰县| 洪洞县| 琼海市| 朝阳县| 华蓥市| 绥化市| 毕节市| 上饶市| 龙海市| 郴州市| 炉霍县| 海淀区| 麻栗坡县| 泸水县|